{"entity":{"type":"insider","cik":"0001326765","url":"/insider/0001326765","json_url":"/insider/0001326765.json","name":"Plavan Matthew T","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":21,"n_filings":13,"first":"2015-09-04","last":"2026-01-20","span_basis":"filed_date"},"name_variants":[{"name":"Plavan Matthew T","source":"filing","n_filings":13,"first_seen":"2015-09-04","last_seen":"2026-01-20"}],"transactions":[{"id":6156473,"accession":"0001326765-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001326765-26-000002","line_url":"/filing/0001326765-26-000002#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Origin Materials, Inc.","issuer_ticker":"ORGN","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (CFO and COO)","officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":0.1994,"price_display":"0.20","price_state":"stated","total_value":2392.8,"total_display":"2,392.80","shares_owned_after":1308231.0,"shares_owned_after_display":"1,308,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-16","filed_date":"2026-01-20","scope":"insider"},{"id":4465250,"accession":"0001326765-25-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001326765-25-000007","line_url":"/filing/0001326765-25-000007#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Origin Materials, Inc.","issuer_ticker":"ORGN","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (CFO and COO)","officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":0.2096,"price_display":"0.21","price_state":"stated","total_value":8384.0,"total_display":"8,384.00","shares_owned_after":1320231.0,"shares_owned_after_display":"1,320,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-26","filed_date":"2025-12-29","scope":"insider"},{"id":4465247,"accession":"0001326765-25-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001326765-25-000006","line_url":"/filing/0001326765-25-000006#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Origin Materials, Inc.","issuer_ticker":"ORGN","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (CFO and COO)","officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":0.55,"price_display":"0.55","price_state":"stated","total_value":82500.0,"total_display":"82,500.00","shares_owned_after":1360231.0,"shares_owned_after_display":"1,360,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-03","filed_date":"2025-11-04","scope":"insider"},{"id":5080209,"accession":"0001415889-25-007367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-25-007367","line_url":"/filing/0001415889-25-007367#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Origin Materials, Inc.","issuer_ticker":"ORGN","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (CFO and COO)","officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9725.0,"shares_display":"9,725","price_per_share":0.8579,"price_display":"0.86","price_state":"stated","total_value":8343.0775,"total_display":"8,343.08","shares_owned_after":1510231.0,"shares_owned_after_display":"1,510,231","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-05","filed_date":"2025-03-07","scope":"insider"},{"id":3179557,"accession":"0001415889-24-030315","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001415889-24-030315","line_url":"/filing/0001415889-24-030315#line-2","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Origin Materials, Inc.","issuer_ticker":"ORGN","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (CFO and COO)","officer_title":"CFO and COO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24500.0,"shares_display":"24,500","price_per_share":1.0249,"price_display":"1.02","price_state":"stated","total_value":25110.05,"total_display":"25,110.05","shares_owned_after":1439588.0,"shares_owned_after_display":"1,439,588","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-27","filed_date":"2024-12-31","scope":"insider"},{"id":2223197,"accession":"0001415889-24-026277","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001415889-24-026277","line_url":"/filing/0001415889-24-026277#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Origin Materials, Inc.","issuer_ticker":"ORGN","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120000.0,"shares_display":"120,000","price_per_share":1.3155,"price_display":"1.32","price_state":"stated","total_value":157860.0,"total_display":"157,860.00","shares_owned_after":1223088.0,"shares_owned_after_display":"1,223,088","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-11-04","filed_date":"2024-11-06","scope":"insider"},{"id":5034613,"accession":"0001209191-21-005219","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-005219","line_url":"/filing/0001209191-21-005219#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":585.0,"shares_display":"585","price_per_share":3.16,"price_display":"3.16","price_state":"stated","total_value":1848.6,"total_display":"1,848.60","shares_owned_after":14285.0,"shares_owned_after_display":"14,285","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-08-03","filed_date":"2021-01-25","scope":"insider"},{"id":3233897,"accession":"0001209191-20-006282","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-006282","line_url":"/filing/0001209191-20-006282#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":700.0,"shares_display":"700","price_per_share":1.72,"price_display":"1.72","price_state":"stated","total_value":1204.0,"total_display":"1,204.00","shares_owned_after":13700.0,"shares_owned_after_display":"13,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-03","filed_date":"2020-02-04","scope":"insider"},{"id":8601521,"accession":"0001209191-19-056884","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-056884","line_url":"/filing/0001209191-19-056884#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.0795,"price_display":"4.08","price_state":"stated","total_value":4079.5,"total_display":"4,079.50","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-11-14","filed_date":"2019-11-18","scope":"insider"},{"id":7806754,"accession":"0001209191-19-050493","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-050493","line_url":"/filing/0001209191-19-050493#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":5.25,"price_display":"5.25","price_state":"stated","total_value":10500.0,"total_display":"10,500.00","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-23","filed_date":"2019-09-23","scope":"insider"},{"id":7806586,"accession":"0001209191-19-049077","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-049077","line_url":"/filing/0001209191-19-049077#line-2","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.5205,"price_display":"6.52","price_state":"stated","total_value":6520.5,"total_display":"6,520.50","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-10","scope":"insider"},{"id":7806583,"accession":"0001209191-19-049077","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-049077","line_url":"/filing/0001209191-19-049077#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Executive Officer)","officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.493,"price_display":"6.49","price_state":"stated","total_value":6493.0,"total_display":"6,493.00","shares_owned_after":9000.0,"shares_owned_after_display":"9,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-10","scope":"insider"},{"id":9270958,"accession":"0001209191-19-047582","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-7","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":6.88,"price_display":"6.88","price_state":"stated","total_value":6880.0,"total_display":"6,880.00","shares_owned_after":8000.0,"shares_owned_after_display":"8,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-28","filed_date":"2019-08-28","scope":"insider"},{"id":9270957,"accession":"0001209191-19-047582","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-4","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.3,"price_display":"9.30","price_state":"stated","total_value":9300.0,"total_display":"9,300.00","shares_owned_after":4000.0,"shares_owned_after_display":"4,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-28","scope":"insider"},{"id":9270956,"accession":"0001209191-19-047582","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-3","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.32,"price_display":"9.32","price_state":"stated","total_value":9320.0,"total_display":"9,320.00","shares_owned_after":3000.0,"shares_owned_after_display":"3,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-28","scope":"insider"},{"id":9270953,"accession":"0001209191-19-047582","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-6","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2000.0,"shares_display":"2,000","price_per_share":8.93,"price_display":"8.93","price_state":"stated","total_value":17860.0,"total_display":"17,860.00","shares_owned_after":7000.0,"shares_owned_after_display":"7,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-28","scope":"insider"},{"id":9270952,"accession":"0001209191-19-047582","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-5","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.95,"price_display":"8.95","price_state":"stated","total_value":8950.0,"total_display":"8,950.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-27","filed_date":"2019-08-28","scope":"insider"},{"id":9270955,"accession":"0001209191-19-047582","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-2","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":9.22,"price_display":"9.22","price_state":"stated","total_value":9220.0,"total_display":"9,220.00","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-28","scope":"insider"},{"id":9270954,"accession":"0001209191-19-047582","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-047582","line_url":"/filing/0001209191-19-047582#line-1","is_derivative":false,"issuer_cik":"0001326765","issuer_name":"Arcadia Biosciences, Inc.","issuer_ticker":"RKDA","issuer_name_source":null,"issuer_url":"/issuer/0001326765","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":8.33,"price_display":"8.33","price_state":"stated","total_value":8330.0,"total_display":"8,330.00","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-08-26","filed_date":"2019-08-28","scope":"insider"},{"id":8905991,"accession":"0001140361-15-034506","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001140361-15-034506","line_url":"/filing/0001140361-15-034506#line-2","is_derivative":false,"issuer_cik":"0000811212","issuer_name":"CESCA THERAPEUTICS INC.","issuer_ticker":"KOOL","issuer_name_source":null,"issuer_url":"/issuer/0000811212","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Former CEO)","officer_title":"Former CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11400.0,"shares_display":"11,400","price_per_share":0.68,"price_display":"0.68","price_state":"stated","total_value":7752.0,"total_display":"7,752.00","shares_owned_after":250937.0,"shares_owned_after_display":"250,937","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-02","filed_date":"2015-09-04","scope":"insider"},{"id":8905990,"accession":"0001140361-15-034506","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-15-034506","line_url":"/filing/0001140361-15-034506#line-1","is_derivative":false,"issuer_cik":"0000811212","issuer_name":"CESCA THERAPEUTICS INC.","issuer_ticker":"KOOL","issuer_name_source":null,"issuer_url":"/issuer/0000811212","owner_cik":"0001326765","owner_name":"Plavan Matthew T","owner_url":"/insider/0001326765","role":"Officer (Former CEO)","officer_title":"Former CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5871.0,"shares_display":"5,871","price_per_share":0.6875,"price_display":"0.69","price_state":"stated","total_value":4036.3125,"total_display":"4,036.31","shares_owned_after":245066.0,"shares_owned_after_display":"245,066","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-02","filed_date":"2015-09-04","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":21,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":13,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":21},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001802457","name":"Origin Materials, Inc.","url":"/issuer/0001802457","role":"Officer (CFO and COO)","n_filings":6,"first_seen":"2024-11-06","last_seen":"2026-01-20"},{"type":"issuer","type_label":"ISSUER","cik":"0001469443","name":"Arcadia Biosciences, Inc.","url":"/issuer/0001469443","role":"Officer (Chief Executive Officer)","n_filings":6,"first_seen":"2019-08-28","last_seen":"2021-01-25"},{"type":"issuer","type_label":"ISSUER","cik":"0000811212","name":"CESCA THERAPEUTICS INC.","url":"/issuer/0000811212","role":"Officer (Former CEO)","n_filings":1,"first_seen":"2015-09-04","last_seen":"2015-09-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001326765","retrieved_at":"2026-08-20T22:33:09+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}